Niedrobnokomórkowy rak płuca: badanie fazy II/III leku paclitaxel i cisplatin
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic…